Not just a simple "split": The multifaceted considerations behind the sale of WUXI APPTEC's CGT Business.

In an era where Globalization and protectionism coexist, the rapid iteration of cutting-edge technologies, alongside multiple constraints from policies and capital, poses unprecedented challenges for pharmaceutical innovation companies.

wallstreetcn19:50 ET

WuXi AppTec Announces EGM to Elect New Director

TipRanksDec 31, 2024 04:38 ET

The Hang Seng Index fluctuates around the 20,000-point mark, and short-term new stocks are seeing a return of profit-making effects ｜ A barometer of Hong Kong stocks.

① The Hang Seng Index is fluctuating around the 20,000 point mark, what hot topics is the market focusing on? ② The return of short-term new stock profitability effects, what impact does it have?

cls.cnDec 30, 2024 07:44 ET

WUXI APPTEC has been selected for the Dow Jones Sustainability Index (DJSI) for four consecutive years.

Shanghai, December 30, 2024 /PR Newswire/ -- WUXI APPTEC recently announced that it has been selected for the 2024 Dow Jones Sustainability World Index (DJSI World) and the Emerging Markets Index (DJSI Emerging Markets), marking the fourth consecutive year that WUXI APPTEC has been included in the Dow Jones Sustainability Index (DJSI), which demonstrates the company's strong commitment to promoting sustainable development and practicing responsible business practices. The DJSI is the globally recognized benchmark for sustainability, assessing enterprises' long-term economic, environmental, and social performance.

PR NewswireDec 30, 2024 07:00 ET

WuXi AppTec's Commitment to Sustainability Recognized by the Dow Jones Sustainability Indices (DJSI) for the Fourth Consecutive Year

PR NewswireDec 30, 2024 07:00 ET

Minsheng Securities: Triple resonance moving upwards, focusing on pharmaceutical innovation and Consumer in 2025.

Looking ahead to 2025, there is a bullish outlook on the upward resonance of policy, fundamentals, and market sentiment, comprehensively optimistic about the pharmaceutical sector, with a focus on high-quality assets in pharmaceutical innovation and consumer sectors.

Zhitong FinanceDec 30, 2024 03:55 ET